Repetitive Transcranial Magnetic Stimulation in Subjects With Early Psychosis and The Functional Connectivity Biotypes

Status: Recruiting
Location: See all (6) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The present study plans to explore different cortical targets of repetitive transcranial magnetic stimulation (rTMS) for populations at the early phase of psychosis, including those at clinical high risk of psychosis and in the first episode of psychosis. The clinical augmentation efficacy will be associated with the brain functional connectivity of these populations.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 14
Maximum Age: 45
Healthy Volunteers: f
View:

• Meeting the syndrome of clinical high risk of psychosis, identified by a face-to-face interview using the Chinese version of Structured Interview for Prodromal Syndromes / Scale of Prodromal Symptoms (SIPS/SOPS);

• Given the written consent for participation.

• Age between 14-45 years old;

• IQ\>69;

• PANSS total scores \>= 55 or BVMT-R score \<= 26;

• Meeting the DSM-V diagnostic criteria for schizophrenia spectrum disorders;

• Given the written consent for participation.

• Age between 14-45 years old;

• IQ\>69;

• during the first episode without a full remission;

• PANSS total scores \>= 55 or BVMT-R score \<= 26;

• within receiving rTMS, patients can receive second-generation antipsychotics except clozapine with stable dosages

Locations
Other Locations
China
The Affiliated Brain Hospital of Guangzhou Medical University
NOT_YET_RECRUITING
Guangzhou
Nantong Fourth People's Hospital & Nantong Brain Hospital
RECRUITING
Nantong
Shanghai Mental Health Center
RECRUITING
Shanghai
Shenzhen Kangning Hospital
RECRUITING
Shenzhen
Suzhou Guangji Hospital
RECRUITING
Suzhou
Tianjin Anding Hospital
RECRUITING
Tianjin
Contact Information
Primary
Jijun Wang, M.D, Ph.D
jijunwang27@163.com
86-21-34773065
Time Frame
Start Date: 2020-08-01
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 300
Treatments
Active_comparator: Active TMS targeting both cerebellum and right dorsolateral prefrontal cortex.
Subjects identified as with prominent negative symptoms will be randomized into active group, who will receive active rTMS over cerebellum and right dorsolateral prefrontal cortex navigated by individual MRI.
Sham_comparator: Sham TMS targeting both cerebellum and right dorsolateral prefrontal cortex
Subjects identified as with prominent negative symptoms will be randomized into sham group, who will receive sham rTMS over cerebellum and right dorsolateral prefrontal cortex navigated by individual MRI.
Active_comparator: Active TMS targeting left inferior parietal lobule
Subjects identified with prominent cognition deficits wil be randomized into active group, who will receive active rTMS over left inferior parietal lobule, navigated by individual MRI and functional connectivity map with left hippocampus.
Placebo_comparator: Sham TMS targeting left inferior parietal lobule
Subjects identified with prominent cognition deficits wil be randomized into sham group, who will receive sham rTMS over left inferior parietal lobule, navigated by individual MRI and functional connectivity map with left hippocampus.
Active_comparator: Active deep TMS using Brainways H7 coil targeting ACC
Subjects identified as with positive symptoms will be randomized into active group, who will receive active deep rTMS over ACC using H7 coil.
Placebo_comparator: Sham deep TMS using Brainways H7 coil targeting ACC
Subjects identified with positive symptoms will be randomized into sham group, who will receive sham deep rTMS over ACC using H7 coil.
Related Therapeutic Areas
Sponsors
Collaborators: Suzhou Psychiatric Hospital, Tianjin Anding Hospital, Nantong Fourth People's Hospital & Nantong Brain Hospital, Shenzhen Kangning Hospital, Guangzhou Psychiatric Hospital
Leads: Shanghai Jiao Tong University School of Medicine

This content was sourced from clinicaltrials.gov

Similar Clinical Trials